NCT03923244

Brief Summary

The main objective is to describe the characteristics of dry eye syndrome before and after surgery at one month of cataract surgery, using a multimodal analysis of the ocular surface. The secondary objectives are to evaluate:

  • Predictive factors of dry eye syndrome during cataract surgery:
  • The characteristics of dry eye syndrome
  • Implications for the patient's quality of life

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2019

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

April 5, 2019

Completed
17 days until next milestone

First Posted

Study publicly available on registry

April 22, 2019

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 6, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 6, 2020

Completed
Last Updated

April 24, 2020

Status Verified

April 1, 2020

Enrollment Period

11 months

First QC Date

April 5, 2019

Last Update Submit

April 23, 2020

Conditions

Keywords

Dry Eye Syndrometear film analysisocular surfacecataract surgery

Outcome Measures

Primary Outcomes (1)

  • The main objective is to describe the characteristics of dry eye syndrome before and after surgery at one month of cataract surgery, using a multimodal analysis of the ocular surface.

    Definition and classification of a dry eye syndrome according to different severity grades with an analysis of the ocular surface

    Change from Baseline one month after surgery

Secondary Outcomes (3)

  • Predictive factors of dry eye syndrome during cataract surgery

    Day 1, Day 30

  • The characteristics of dry eye syndrome

    Day 1, Day 30

  • Consequences on the patient's quality of life (translated questionnaire from the Ocular Surface Disease Index from 0 to 48)

    Day 1, Day 30

Study Arms (1)

cohorte 1

EXPERIMENTAL

Normal patient consultation schedule for cataract surgery with: * Preoperative appointment scheduled for the patient * Post-operative appointment 1 month before surgery No additional appointments. After geting consent and during the two consultations: * Completion of a quality of life survey by the patient. Collection of the patient's history and general and ophthalmological treatments. Questionnaire of 12 items on quality of life to be completed. For each question, the patient must answer on the frequency of the discomfort felt, from "never" to "all the time". * An analysis of the ocular surface is performed by a non-invasive and non-contact device for 4 minutes. This consists of taking different photographs of the eye and eyelids, allowing each to study a part of the tears. * Schirmer test is performed, consisting of applying the end of a small strip of blotting paper behind the lower eyelid and examining the strip after 5 minutes.

Diagnostic Test: OSDI survey

Interventions

OSDI surveyDIAGNOSTIC_TEST

Normal patient consultation schedule for cataract surgery with: * Preoperative appointment scheduled for the patient * Post-operative appointment 1 month before surgery No additional appointments. After geting consent and during the two consultations: * Completion of a quality of life survey by the patient. Collection of the patient's history and general and ophthalmological treatments. Questionnaire of 12 items on quality of life to be completed. For each question, the patient must answer on the frequency of the discomfort felt, from "never" to "all the time". * An analysis of the ocular surface is performed by a non-invasive and non-contact device for 4 minutes. This consists of taking different photographs of the eye and eyelids, allowing each to study a part of the tears. * Schirmer test is performed, consisting of applying the end of a small strip of blotting paper behind the lower eyelid and examining the strip after 5 minutes.

Also known as: Schirmer test, Lacrydiag test
cohorte 1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients (≥ 18 years old)
  • consultants to benefit from a scheduled cataract operation at Clermont Ferrand University Hospital
  • affiliation to a social security scheme
  • ability to give informed consent to participate in the study.

You may not qualify if:

  • \- Patient without cataract surgery
  • Congenital cataract
  • Refusal to participate in the study
  • Inability to answer the questionnaire (cognitive impairment, comprehension difficulties...)
  • Eyelid abnormalities that may cause palpebral unocclusion
  • Patient under judicial protection (guardianship, curatorship, measure to safeguard justice) or deprived of liberty
  • inability to recheck the patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Clermont-Ferrand

Clermont-Ferrand, 63000, France

Location

MeSH Terms

Conditions

Dry Eye Syndromes

Interventions

Wettability

Condition Hierarchy (Ancestors)

Lacrimal Apparatus DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

Hydrophobic and Hydrophilic InteractionsChemical PhenomenaSurface Properties

Study Officials

  • frédéric Chiambaretta

    University Hospital, Clermont-Ferrand

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Descriptive study, interventional research involving the human person at risk and with minimal constraints (type 2), prospective, with longitudinal cohort follow-up, mono-centric
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 5, 2019

First Posted

April 22, 2019

Study Start

April 1, 2019

Primary Completion

March 6, 2020

Study Completion

March 6, 2020

Last Updated

April 24, 2020

Record last verified: 2020-04

Locations